Published in Arch Mal Coeur Vaiss on September 01, 1986
Right ventricular dysplasia: a report of 24 adult cases. Circulation (1982) 6.54
Prevalence of patent foramen ovale in patients with stroke. N Engl J Med (1988) 5.94
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J (1981) 2.41
False-positive HIV antigens related to emergence of a 25-30 kD protein detected in organ recipients. AIDS (1992) 1.82
[Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia]. Arch Mal Coeur Vaiss (1978) 1.69
Renal tolerance for ioxaglate in patients with chronic renal failure. Radiology (1991) 1.42
[Beta-blockers in the treatment of heart failure]. Presse Med (1990) 1.39
[Arrhythmogenic right ventricular dysplasia and Uhl's disease]. Arch Mal Coeur Vaiss (1982) 1.38
Left coronary artery aneurysm and anteroseptal acute myocardial infarction following blunt chest trauma. Eur Heart J (1986) 1.27
[Nosologic frontiers of arrhythmogenic dysplasia. Quantitative variations of normal adipose tissue of the right heart ventricle]. Arch Mal Coeur Vaiss (1991) 1.19
Anomalous coronary arteries coursing between the aorta and pulmonary trunk: clinical indications for coronary artery bypass. Eur Heart J (1991) 1.12
[Angiocardiographic diagnosis in right ventricular dysplasias]. Arch Mal Coeur Vaiss (1985) 1.10
[Effect of amiodarone on cardiac rhythm and electrocardiograms]. Therapie (1972) 1.10
Spontaneous coronary artery dissection: case report and evidence for a defect in collagen metabolism. Eur Heart J (1986) 1.08
Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation (1995) 1.06
Arrhythmogenic right ventricular dysplasia: a clinical model for the study of chronic ventricular tachycardia. Jpn Circ J (1984) 1.06
[Electrocardiography of delayed potentials in post-excitation syndrome]. Arch Mal Coeur Vaiss (1978) 1.05
[Cardiac involvement in Behçet's disease. 12 cases]. Presse Med (1988) 1.01
(1)H NMR-based metabolomics approach for exploring urinary metabolome modifications after acute and chronic physical exercise. Anal Bioanal Chem (2009) 0.99
Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation (1992) 0.98
Torsades de pointes: definition and management. Mod Concepts Cardiovasc Dis (1982) 0.97
[Permanent intra-hisian atrioventricular block induced during right intraventricular exploration]. Arch Mal Coeur Vaiss (1979) 0.97
Intracardiac conduction defects in dystrophia myotonica. Electrophysiological study of 12 cases. Br Heart J (1980) 0.95
Oxidative stress in patients with unstable angina. Eur Heart J (1994) 0.94
Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol (1998) 0.94
Evidence of the inaccuracy of standard echocardiographic and angiographic criteria used for the recognition of true and "false" left ventricular inferior aneurysms. Br Heart J (1988) 0.93
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation (2001) 0.93
Emergency percutaneous coronary dilatation for acute myocardial infarction in Behçet's disease. Eur Heart J (1987) 0.93
Modern concepts of ventricular tachycardia. The value of electrocardiological investigations and delayed potentials in ventricular tachycardia of ischemic and nonischemic etiology (31 operated cases). Eur J Cardiol (1978) 0.92
Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron (1993) 0.91
[Significance of intraventricular conduction disorders observed in arrhythmogenic right ventricular dysplasia]. Arch Mal Coeur Vaiss (1984) 0.91
Results of percutaneous catheter valvuloplasty for calcified aortic stenosis in the elderly. Eur Heart J (1987) 0.90
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol (2000) 0.90
Assessment of the optimal atrio-ventricular delay in DDD paced patients by impedance plethysmography. Eur Heart J (1989) 0.90
Right heart failure due to an inter-atrial shunt after percutaneous mitral balloon dilatation. Eur Heart J (1989) 0.89
Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. Br J Cancer (1992) 0.89
[Cerebral vascular accidents in young subjects. A study of 133 patients 9 to 45 years of age]. Rev Neurol (Paris) (1989) 0.88
[Aneurysm of the interauricular septum revealed by a cerebral embolism]. Arch Mal Coeur Vaiss (1973) 0.88
Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study. Eur Heart J (1992) 0.88
Particle deposition and resistance in the noses of adults and children. Eur Respir J (1991) 0.88
[Aortic insufficiency in Takayasu's disease. Apropos of 3 surgically treated cases and review of the literature]. Arch Mal Coeur Vaiss (1984) 0.87
Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation (1997) 0.87
Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris. Circulation (2001) 0.87
Diagnosis of pulmonary embolism by transoesophageal echocardiography. Eur Heart J (1992) 0.87
[Mitral valvuloplasty during the 4th month of pregnancy. Fetal protection with a lead mantle]. Arch Mal Coeur Vaiss (1991) 0.86
Identification of a zone of slow conduction appropriate for VT ablation: theoretical and practical considerations. Pacing Clin Electrophysiol (1989) 0.85
Coronary artery spasm in a transplant patient. Eur Heart J (1988) 0.85
[Arterial lesions produced in rabbits by immunisation with elastin and structural glycoproteins of aorta. Biochemical and morphological studies]. Atherosclerosis (1972) 0.85
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol (1997) 0.84
Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways. Eur Respir J (1988) 0.84
[Echocardiographic study of the effects of a nitroglycerin microcapsule preparation (author's transl)]. Nouv Presse Med (1980) 0.84
[Paradoxal cerebral embolism: role of patent oval foramen]. Bull Acad Natl Med (1990) 0.83
[Peripheral calcific embolism after percutaneous mitral valvuloplasty]. Arch Mal Coeur Vaiss (1992) 0.83
Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. Cancer Res (1996) 0.83
Plasma calcitonin gene-related peptide decreases in chronic congestive heart failure. Eur Heart J (1992) 0.82
Surgical management of ventricular tachycardia unrelated to myocardial ischemia or infarction. Am J Cardiol (1982) 0.82
[Recurrent ventricular tachycardia and parchment right ventricle in the adult. Anatomical and clinical report of 2 cases]. Arch Mal Coeur Vaiss (1978) 0.82
Systemic embolism as a complication of percutaneous mitral valvuloplasty. Cathet Cardiovasc Diagn (1992) 0.82
[Immunologic study of dilated cardiomyopathies]. Arch Mal Coeur Vaiss (1982) 0.82
Doppler echocardiography for the diagnosis of acute cardiac allograft rejection. J Am Coll Cardiol (1988) 0.82
[Causes of sudden death in athletes]. Arch Mal Coeur Vaiss (1989) 0.82
[HLA A-B and DR in dilated myocardiopathies]. Arch Mal Coeur Vaiss (1987) 0.81
Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg (1998) 0.81
[Assessment of the degree of severity of aortic stenosis. Clinical, mechanographic, echographic and hemodynamic study of 22 cases]. Arch Mal Coeur Vaiss (1981) 0.81
The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant (2000) 0.81
[Arrhythmogenic dysplasia. Nosologic relation with Uhl's syndrome and lipomatosis. Apropos of 3 anatomo-clinical cases]. Arch Anat Cytol Pathol (1986) 0.81
[Congenital and acquired right ventricular dysplasia]. Arch Mal Coeur Vaiss (1990) 0.81
[Contribution of in vitro NMR spectroscopy to metabolic and neurodegenerative disorders]. Rev Neurol (Paris) (2007) 0.80
[Treatment of angina pectoris with amiodarone]. Presse Med (1969) 0.80
[Prevalence of patent foramen ovale in young patients with ischemic cerebral complications]. Arch Mal Coeur Vaiss (1989) 0.80
Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress tests. Am J Cardiol (1999) 0.80
Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin. J Am Coll Cardiol (1994) 0.79
[Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia]. Arch Mal Coeur Vaiss (1989) 0.79
Coronary blood flow reserve measured by contrast media injection depends on myocardial viability. Eur Heart J (1991) 0.79
Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia. Pacing Clin Electrophysiol (1988) 0.79
Non-invasive study of dual chamber pacing by pulsed Doppler. Prediction of the haemodynamic response by echocardiographic measurements. Eur Heart J (1989) 0.79
[Kent's bundle section in a case of A-B Wolff-Parkinson-White syndrome. 2. Epicardic cartographies]. Arch Mal Coeur Vaiss (1972) 0.79
[Interatrial septal aneurysm. Echocardiographic diagnosis]. Arch Mal Coeur Vaiss (1984) 0.79
A dynamic analysis of the ventilatory response to carbon dioxide inhalation in man. J Physiol (1988) 0.79
[Refractory periods of intracardiac conduction. Definitions and normal values in humans]. Coeur Med Interne (1976) 0.79
[Method of recording the bundle of His externally]. Nouv Presse Med (1977) 0.79
Lack of platelet-activating factor release during reversible myocardial ischaemia. Eur Heart J (1992) 0.78